\
&
Contact us
\
&
Contact us
Published on | 4 days ago
Programmes HealthThe European Partnership for Personalised Medicine (EP PerMed) has launched its second joint transnational call (JTC2025) for proposals on “Pharmacogenomic strategies for personalised medicine approaches (PGxPM2025)”. In total, 35 funding organisations participate in this call with an available budget of over € 36.5 Mio.
The topics of this call are the following:
Pay attention: projects focussing only on drug-drug-interaction and projects focusing on the clinical development of new drugs are not eligible.
Research Foundation Flanders (FWO) participates in this call. More information on available funding for researchers based in Flanders and on how to apply can be found on the dedicated FWO webpage. Interested to apply? Contact the FWO advisors at europe@fwo.be. Deadline for pre-proposal submission AND national pre-application via the FWO e-loket is 18 February 2025, 14:00 CET.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Autoship is, as the name suggests, an acronym for autonomous ship. Just like with self-driving cars, the possibilities of an unmanned boat seem endless. It can create more efficient freight transport, around the clock deliveries and these are just a few of the examples. The project has two societal challenges.
At first, De Vlaamse Waterweg was a bit hesitant as their experience with FP7 or Horizon 2020 projects was limited and they had not been very successful up until then. The fact that they were already doing basic research on the topic of autonomous boats, and the administrative help of NCP FLanders helped De Vlaamse waterweg to cross the line and get involved.
